Compare LXFR & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LXFR | SOPH |
|---|---|---|
| Founded | 1898 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 322.5M | 330.4M |
| IPO Year | 2012 | 2021 |
| Metric | LXFR | SOPH |
|---|---|---|
| Price | $14.05 | $4.74 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 119.4K | 75.4K |
| Earning Date | 10-28-2025 | 11-04-2025 |
| Dividend Yield | ★ 3.70% | N/A |
| EPS Growth | ★ 55.43 | N/A |
| EPS | ★ 0.53 | N/A |
| Revenue | ★ $397,300,000.00 | $73,297,000.00 |
| Revenue This Year | $0.62 | $18.32 |
| Revenue Next Year | N/A | $15.61 |
| P/E Ratio | $23.43 | ★ N/A |
| Revenue Growth | 3.36 | ★ 13.66 |
| 52 Week Low | $9.41 | $2.58 |
| 52 Week High | $14.96 | $5.30 |
| Indicator | LXFR | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 72.27 | 52.12 |
| Support Level | $12.35 | $4.50 |
| Resistance Level | $14.12 | $4.84 |
| Average True Range (ATR) | 0.31 | 0.22 |
| MACD | 0.06 | -0.03 |
| Stochastic Oscillator | 97.71 | 48.00 |
Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.